Form 4: Omada Health Executive Trades Shares

Sean P. Duffy, CEO and Director of Omada Health, Inc., reported a transaction involving the sale of 9,884 shares of common stock.

Summary

• Sean P. Duffy, Chief Executive Officer and Director of Omada Health, Inc., executed a transaction on June 1, 2026.
• Duffy sold 9,884 shares of common stock at a price of $18.38 per share.
• Following this transaction, Duffy directly owns 440,693 shares.
• Additionally, 851,659 shares are held indirectly in family trusts for the benefit of his family members, though he disclaims beneficial ownership except for his pecuniary interest.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as slightly negative due to the CEO selling shares, which can be interpreted as a bearish signal, although the exact reasons for the sale are not disclosed.

Negatives

• The CEO and Director sold a significant number of shares, which could be perceived negatively by the market.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to insider stock transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While a sale by a CEO can sometimes signal a lack of confidence, it can also be for personal financial planning reasons. The market reaction will depend on the overall context of Omada Health's performance and future prospects.

Related Party Transactions

• Sean P. Duffy disclaims beneficial ownership of shares held in family trusts for the benefit of his family members, except to the extent of his pecuniary interest.

Stakeholder Impact

• Shareholders may view the CEO's sale of shares with caution, potentially impacting short-term stock sentiment.
• Employees may also be influenced by insider trading activity, though the direct impact is minimal unless they are also shareholders.

Key Dates

Recommendation

The filing reports a stock sale by the CEO, which is a neutral to slightly negative event. Without further context on the company's performance or the reason for the sale, a 'hold' recommendation is prudent, allowing investors to await more substantial news or performance indicators.

Keywords

Omada Health, OMDA, Form 4, Insider Trading, Stock Sale, CEO, Director, Beneficial Ownership